Have a personal or library account? Click to login
The issue of the correct use of probiotics in the absence of recommendations Cover

The issue of the correct use of probiotics in the absence of recommendations

Open Access
|Feb 2021

Figures & Tables

Evidence-based adult indications for probiotics, prebiotics, and synbiotics in gastroenterology

Clinical ConditionProbiotic strainRecommended doseReferences
acute diarrhea in adultsLactobacillus paracasei B 21060109 CFU twice daily[16, 66]
Lactobacillus rhamnosus GG109 CFU twice daily
Saccharomyces cerevisiae var. boulardii CNCM I-7455x 109 CFU/capsule

acute gastroenteritis in childrenL. rhamnosus GG≥ 1010 CFU/day[16, 22, 66]
S. boulardii CNCM I745250–750 mg/day
Lactobacillus reuteri DSM 17938108 to 4 × 108 CFU

antibiotic-associated diarrheaL. rhamnosus GG1010 CFU/capsule twice daily[28, 66, 68, 69, 71]
S. boulardii CNCM I-7455 × 109 CFU/capsule
L. reuteri DSM 179381 × 108 CFU twice daily
– Yogurt with Lactobacillus casei DN114, Lactobacillus bulgaricus, and Streptococcus thermophilus≥ 1010 CFU daily
Lactobacillus acidophilus and L. bulgaricus or Bifidobacterium longum

Clostridium difficile-associated diarrheaL. acidophilus CL1285 and L. casei LBC80R5 × 1010 CFU daily and 4–10 × 1010 CFU daily[58, 66, 68]
S. boulardii
5 × 109 CFU/capsule

Helicobacter pylori infectionS. boulardii5 × 109 CFU/capsule[66, 68, 70]
L. rhamnosus GG6 × 109 twice daily
L. casei DN-114 001 (in children)

Irritable Bowel SyndromeBifidobacterium infantis 356241 × 108 CFU/capsule[16, 32, 66, 68, 81]
Bifidobacterium animalis DN-173 0101010 CFU, twice daily
L. plantarum DSM 9843 (299v)10 billion CFU once daily
– VSL#3*

ulcerative colitis (mild to moderate CU for the induction of remission)Escherichia coli Nissle 19175 × 1010 viable bacteria twice daily[6, 47, 66, 72]
– VSL#3

infantile colicL. reuteri DSM 17938108 CFU, once daily[66, 68, 73]
L. rhamnosus GG1010–1011 CFU, twice daily

hepatic encephalopathy– VSL#3108 CFU three times daily[16, 66]

traveler's diarrheaS. boulardii CNCM I-745250–1000 mg, once daily[12]
Language: English
Page range: 107 - 115
Submitted on: Jan 13, 2020
Accepted on: Nov 9, 2020
Published on: Feb 25, 2021
Published by: Hirszfeld Institute of Immunology and Experimental Therapy
In partnership with: Paradigm Publishing Services
Publication frequency: 1 times per year

© 2021 Hanna Tomczak, Marta Wrońska, Paulina Pecyna, Katarzyna Hampelska, published by Hirszfeld Institute of Immunology and Experimental Therapy
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.